The Positive Press Coverage Likely to Affect CME Group (CME) Share Price

The Positive Press Coverage Likely to Affect CME Group (CME) Share Price

These are some of the headlines that may have impacted AlphaOne Sentiment Analysis’s rankings:

News articles about CME Group (NASDAQ:CME) have trended positive recently, according to AlphaOne. The research group, a subsidiary of Accern, identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CME Group earned a media sentiment score of 0.43 on AlphaOne’s scale. AlphaOne also gave media coverage about the financial services provider an impact score of 79 out of 100, meaning that recent media coverage is likely to have an effect on the stock’s share price in the immediate future.

CME Group (CME) opened at 116.93 on Monday. The company’s 50 day moving average is $117.49 and its 200-day moving average is $118.75. The firm has a market cap of $39.73 billion, a price-to-earnings ratio of 25.31 and a beta of 0.88. CME Group has a 1-year low of $92.29 and a 1-year high of $127.60. CME Group (NASDAQ:CME) last announced its earnings results on Thursday, April 27th. The financial services provider reported $1.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.02. CME Group had a net margin of 42.67% and a return on equity of 7.28%. The company had revenue of $929 million during the quarter, compared to the consensus estimate of $932.06 million. During the same period in the previous year, the firm posted $1.15 earnings per share. The company’s revenue was down .5% on a year-over-year basis. On average, analysts predict that CME Group will post $4.86 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, June 26th. Shareholders of record on Friday, June 9th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date of this dividend is Wednesday, June 7th. CME Group’s dividend payout ratio is presently 52.98%. Several equities research analysts have commented on CME shares. Deutsche Bank AG restated a “buy” rating and issued a $133.00 price target (down previously from $134.00) on shares of CME Group in a research note on Monday, May 15th. Jefferies Group LLC restated a “buy” rating and issued a $128.00 price target on shares of CME Group in a research note on Saturday, March 11th. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Monday, March 20th. Finally, Royal Bank of Canada lowered their price objective on shares of CME Group from $133.00 to $130.00 and set an “outperform” rating on the stock in a research note on Monday, May 1st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $116.88.

The business also recently announced a quarterly dividend, which will be paid on Monday, June 26th. Shareholders of record on Friday, June 9th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date of this dividend is Wednesday, June 7th. CME Group’s dividend payout ratio is presently 52.98%. In related news, Director Dennis Suskind sold 1,099 shares of the business’s stock in a transaction that occurred on Friday, April 28th. The shares were sold at an average price of $115.29, for a total transaction of $126,703.71. Following the completion of the sale, the director now directly owns 5,000 shares of the company’s stock, valued at $576,450. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Sunil Cutinho sold 10,265 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $117.85, for a total transaction of $1,209,730.25. Following the sale, the insider now directly owns 21,690 shares of the company’s stock, valued at $2,556,166.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 16,907 shares of company stock valued at $2,009,182. Insiders own 0.61% of the company’s stock.

About CME Group CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:CME”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for CME Group Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment